Yes, that is what we believe. Our focus is to understand the unique life of stem cells. We aim to gain a comprehensive understanding of the endogenously produced stem cell factors and their role in directing stemness in development and in cancer. Our research combines quantitative proteomics and high-resolution sequencing with cutting-edge stem cell and genetic engineering techniques. The ultimate aim is to boost the development of regenerative medicine and cancer therapies.
Can be reprogrammed from somatic
patient-specific cells
Can be isolated from the inner cell mass of blastocyst-stage embryos